Guest opinion writer Tony Sheridan says that a number of discussions are taking place in Congress and Hartford regarding healthcare costs. And while Congress is considering action that could actually lower the cost of healthcare, state legislators are debating pharmaceutical price controls that run the risk of hindering Research and Development required to develop life-saving drugs.
